CERE (Cerevel Therapeutics Inc) Earnings per share for the last twelve months

Official company branding of Cerevel Corp (CERE)

High R&D costs and dependence on regulatory verdicts create significant challenges for Cerevel Therapeutics (CERE). The current state of annual EPS TTM growth clearly demonstrates these volatile processes, with the indicator fixed at -17.80. Meanwhile, Cerevel Therapeutics (CERE) is focusing on developing targeted Alzheimer's drugs, relying on a diversified network of laboratories to ensure an uninterrupted supply of raw materials.

cerevel.com (CERE): Earnings per share for the last twelve months from 02/11/2024 to 02/20/2024

Financial and market metric breakdowns for Cerevel (CERE)

- price and consensus price forecast:
- business market valuation indicators:
Fundamental company valuation:Cerevel Therapeutics, Inc. CERE
Product sample of Cerevel Therapeutics Inc

This metric calculates the percentage change in net income per share over the last twelve months relative to the same period last year. It measures operational efficiency dynamics and capital sensitivity to market shocks. For Cerevel Therapeutics (CERE), which depends on external investments and the completion of clinical trials, this indicator reflects the cash burn rate. Analyzing the current annual EPS TTM growth value allows for an assessment of the company's financial stability prior to bringing drugs to market.

Competitor analysis for Cerevel Therapeutics

Net earnings per share for the trailing year Biogen (BIIB)|neurocrine.com (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell|AXSM (Axsome) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ACADIA Pharmaceuticals Inc.|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Supernus Corp SUPN|Earnings per share for the last four quarters CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Net earnings per share (EPS TTM)|HRMY: Earnings per share for the last twelve months|Biohaven (BHVN) - Earnings per share for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Net earnings per share (EPS TTM)|TRVI (Trevi Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Praxis Medicines (PRAX)|Net earnings per share for the last 12 months AVXL (Anavex Life Sciences)|Net earnings per share for the last 12 months CeriBell CBLL|Earnings per share for the last twelve months Prothena Biosciences PRTA|Net earnings per share (EPS TTM) Alector, Inc. ALEC|ANNX - Earnings per share for the last twelve months|OMER - Net earnings per share (EPS TTM)|Neurogene (NGNE) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months AC Immune SA (ACIU)|Net earnings per share for the last 12 months VYGR|Net earnings per share (EPS TTM) Neumora Therapeutics Inc|Earnings per share for the last twelve months scilexholding.com (SCLX)|Net earnings per share for the last four quarters Tevogen Bio Inc.|Earnings per share for the last twelve months Alpha Cognition Inc. ACOG|Net earnings per share (EPS TTM) Cognition Therapeutics CGTX|IKT: Net earnings per share for the last 12 months|SAVA (Cassava Sciences) - Earnings per share for the last 12 months|Assertio Holdings, Inc. (ASRT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months COYA|Earnings per share for the last twelve months Vistagen|Net earnings per share for the last 12 months Ovid Therapeutics (OVID)|Earnings per share for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Net earnings per one share for the last twelve months|Alterity Therapeutics Limited - Net earnings per share for the last 12 months|CLNN: Earnings per share for the last 12 months|pepgen.com - Net earnings per share (EPS TTM)|JUNS (Jupiter Neurosciences) - Earnings per share for the last 12 months|Relmada (RLMD) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Net earnings per share (EPS TTM)|Firefly Neuroscience Inc (AIFF) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) RVPH (Reviva Pharmaceuticals, Inc.)|Earnings per share for the trailing year MTVA|NeurAxis Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Helius Medical Technologies, Inc. HSDT|PASG: Net earnings per share (EPS TTM)|Neuphoria (NEUP) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Minerva Neurosciences Inc|Athira Pharma Inc (ATHA) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ADXN (Addex Therapeutics)|Net earnings per share (EPS TTM) Alzamend Neuro Inc. (ALZN)|Cyclerion Therapeutics, Inc. - Net earnings per share for the last 12 months|PTIX (Protagenic Therapeutics) - Earnings per one share for the last 12 months|Pasithea Therapeutics Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cortigent CRGT|ATXI (Avenue Therapeutics, Inc) - Net earnings per share for the last 12 months|Brainstorm Cell Therapeutics, Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months CARA|Net earnings per one share for the last twelve months chromocell.com CHRO|Earnings per share for the last twelve months Eliem Therapeutics, Inc. (ELYM)|ITCI (Intra-Cellular Therapies, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) LBPH (Longboard Pharmaceuticals Inc)|Net earnings per share (EPS TTM) Marinus Pharma MRNS|nkgenbiotech.com - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NeuroBo Pharmaceuticals, Inc.|Sage Therapeutics (SAGE) - Earnings per share for the last twelve months|SNPX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Trevena, Inc|Vigil Neuroscience (VIGL) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) WENA